Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review

Circulating tumor DNA (ctDNA) has been investigated as a potential noninvasive biomarker for disease prognostication, monitoring, and treatment selection in various tumor types, including renal cell carcinoma (RCC). In this narrative review, we explore the current methods of ctDNA anal...

Full description

Bibliographic Details
Published in:	Société Internationale d’Urologie Journal
Main Authors:	Wesley Yip, A. Ari Hakimi
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	renal cell carcinoma biomarkers ctdna
Online Access:	https://siuj.org/index.php/siuj/article/view/282/232

Similar Items

ctDNA as a novel and promising approach for cancer diagnosis
by: Negin Biglari, et al.
Published: (2023-08-01)

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
by: Estela Sánchez-Herrero, et al.
Published: (2022-07-01)

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review)
by: Aleksandra Englisz, et al.
Published: (2025-05-01)

The role of circulating tumor DNA (ctDNA) in urothelial cancers
by: Jeanny B. Aragon-Ching
Published: (2025-05-01)

Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods
by: Oluwatobi O. Olayode, et al.
Published: (2025-07-01)

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
by: Xiaoling Wang, et al.
Published: (2024-01-01)

Circulating tumor DNA (ctDNA) Detection via electrochemical Biosensing Tools
by: Sonya Sahin, et al.
Published: (2024-06-01)

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy
by: Xiaohong Han, et al.
Published: (2019-10-01)

Liquid Biopsy, ctDNA Diagnosis through NGS
by: Chen Lin, et al.
Published: (2021-08-01)

Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker
by: Li Li, et al.
Published: (2023-12-01)

Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls
by: Holdenrieder Stefan, et al.
Published: (2022-08-01)

Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients
by: Mandy Radefeldt, et al.
Published: (2023-11-01)

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
by: Jiayan Wei, et al.
Published: (2021-10-01)

ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
by: Wang Da, et al.
Published: (2023-05-01)

Utility of Germline, Somatic and ctDNA Testing in Adults With Cancer
by: Emily DeBortoli, et al.
Published: (2025-08-01)

Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages
by: Brittany A. McKelvey, et al.
Published: (2024-04-01)

Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response
by: Christopher T. Boniface, et al.
Published: (2022-05-01)

Multi-analyte liquid biopsy approaches for early detection of esophageal cancer: the expanding role of ctDNA
by: Derek Tai, et al.
Published: (2025-08-01)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
by: Gui‐Qi Zhu, et al.
Published: (2022-01-01)

How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks
by: Estelle Bourbon, et al.
Published: (2021-06-01)

Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients
by: Lydia Warburton, et al.
Published: (2023-12-01)

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing
by: Xianyu Zhang, et al.
Published: (2025-06-01)

Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
by: Christopher T. Boniface, et al.
Published: (2023-03-01)

Circulating tumor DNA laboratory processes and clinical applications in nasopharyngeal carcinoma
by: Ziman Wu, et al.
Published: (2025-05-01)

Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
by: Giovanni Marchi, et al.
Published: (2024-01-01)

Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2023-12-01)

A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs
by: Jianzhu Xie, et al.
Published: (2023-12-01)

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
by: Qiaorui Tan, et al.
Published: (2023-03-01)

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
by: Jason S. Agulnik, et al.
Published: (2022-02-01)

Clinical Utility of ctDNA Analysis in Lung Cancer—A Review
by: Kamil Makar, et al.
Published: (2025-06-01)

Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment
by: Michael E. Egger, et al.
Published: (2024-04-01)

Separation of ctDNA by superparamagnetic bead particles in microfluidic platform for early cancer detection
by: Samla Gauri Balakrishnan, et al.
Published: (2021-11-01)

Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial
by: Joanne Chiu, et al.
Published: (2023-08-01)

Next-Generation Sequencing Analysis of ctDNA for the Detection of Glioma and Metastatic Brain Tumors in Adults
by: Jianfeng Liang, et al.
Published: (2020-08-01)

The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers
by: Ronan J. Kelly, et al.
Published: (2025-02-01)

ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA
by: Ke Wang, et al.
Published: (2024-01-01)

Circulating tumor DNA in patients with cancer: insights from clinical laboratory
by: Illana Francisco J., et al.
Published: (2025-06-01)

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
by: Fulong Wang, et al.
Published: (2023-12-01)

Implementation of circulating tumor DNA (ctDNA) testing in precision oncology: A four-year experience from a tertiary cancer center in India
by: Pradnya Joshi, et al.
Published: (2025-09-01)

Real-World Technical Hurdles of ctDNA NGS Analysis: Lessons from Clinical Implementation
by: Simon Cabello-Aguilar, et al.
Published: (2025-09-01)